Frequency Therapeutics

Frequency Therapeutics is using regenerative medicine to repair or reverse damage caused by degenerative diseases. More than 40 million people in the US suffer from hearing loss which impacts communication and speech perception. While current treatments work to make sounds louder, Frequency is focused on creating the first disease-modifying therapy for sensorineural hearing loss. Frequency’s approach is to restore function with small molecule therapeutics that activate a person’s innate regenerative potential within the body. The molecules temporarily activate progenitor cells in the cochlea within the ear to create a local healing response. FX-322, Frequency’s lead candidate, is in phase 2 clinical trials, with other programs in development.

Jobs: